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Abstract: Small scale experimental model for the preparation of methyl ester of etodolac, the key intermediate in the synthesis of nonsteroidal 
drug etodolac, is thoroughly investigated in order to define the key parameters needed for its large scale production. Oxa-Pictet-Spengler 
reaction of 7-ethyltryptophol and methyl 3-oxopentanoate with inorganic acids as catalysts was monitored over time using HPLC method with 
UV detection. HPLC method for the simultaneous determination of 7-ethyltryptophol and the product was developed first. The conversion of 
7-ethyltryptophol to etodolac precursor was performed using different molar equivalents of acid (1-5 with respect to the β-ketoester) and 
starting 7-ethyltryptophol of different degrees of purity. Kinetic profiles and optimal reaction times were in each case defined and key param-
eters selected. 
 





O ensure controlled and reproducible production of 
pharmaceutical compounds, secure knowledge and 
model for troubleshooting during life cycle of a product as 
well as to embed quality into pharmaceutical products to 
ultimately protect patient safety are the main goals of sys-
tematic quality-by-design (QbD) approach[1,2]. Hence, small 
scale experimental models should be thoroughly investi-
gated first for every active pharmaceutical ingredient. This 
often includes the understanding of critical steps in reac-
tion mechanisms, the study of kinetic profiles for every con-
version, impurity content analysis, etc. High performance 
liquid chromatography (HPLC) is by far the most important 
tool used in the assessment of these parameters. The HPLC 
methods for etodolac, a nonsteroidal drug (NSAID) used in 
humans and domestic animals due to its analgesic, antipy-
retic and antiinflammatory effects,[3] described in literature 
are mostly used for its determination in tablets[4,5], human 
plasma[3,6,7] and in river waters[8]. To the best of our 
knowledge there are no reports that describe the HPLC 
monitoring of conversion of 7-ethyltryptophol (7-ET) to 
etodolac methyl ester (EME), the main precursor in 
etodolac synthesis, over time on any scale. Furthermore, 
there are no methods described for the simultaneous 
determination of 7-ethyltryptophol and etodolac methyl 
ester.  
 The synthetic procedures for the preparation of 
etodolac and its precursors were presented in the past by 
several authors[9–14]. The key intermediate in the etodolac 
synthesis is its alkyl ester which is obtained by the oxa-Pic-
tet-Spengler reaction (Scheme 1) promoted by different 
Brönsted and Lewis acids.[13] Since Lewis acids are often ex-
pensive and difficult to manage in productions on a larger 
scale, inorganic mineral acids (HCl, HBr, H2SO4, H3PO4) are 
preferred.[12] For example, in the report by Vigano and 
Colombo[12] the reaction of 7-ethyltryptophol with methyl 
3-oxopentanoate, conducted in an apolar solvent 
(toluene), the amount of HCl or H2SO4 added was in a molar 
ratio from 0.5 to 5 with respect to 7-ethyltryptophol.  
 The syntheses of tryptophol and its derivatives are 
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purity of the product.[16] As a consequence, 7-ethyl-
tryptophol is accessible on the market in various degrees 
of purity, with some variation in price. The preparation of 
etodolac methyl ester by oxa-Pictet-Spengler reaction 
starting from 7-ethyltryptophol with purity ranging from  
79 to 95 % is reported in several patents.[13,14] Therefore, 
we have developed the HPLC method to monitor the  
oxa-Pictet-Spengler conversion of 7-ethyltryptophol to 
etodolac methyl ester over time. Based on the obtained 
kinetic profiles the optimal reaction conditions and para-




HPLC Method Development and 
Optimization 
Agilent 1220 Infinity LC with variable wavelength detector 
(VWD), an autosampler and thermostated column com-
partment was used for HPLC analysis. UV spectra were rec-
orded on the Varian Cary 3 UV-Vis spectrophotometer. 7-
Ethyltryptophol (99.4 % purity) and etodolac methyl ester 
standards were supplied from PLIVA TAPI Croatia. Chroma-
tographic columns used for the method optimization were 
as follows: Waters Symmetry Shield TM RP 18 (250 mm  4.6 
mm; 5 μm), Waters XBridgeTM Phenyl (150 mm  4.6 mm; 
3.5 μm) and PhenomenexR Luna NH2 (250 mm  4.6 mm; 5 
μm). Elution was performed using different mobile phases: 
ψ (acetonitrile, acetate buffer pH 4) = 55 : 45, ψ (acetoni-
trile, ultra-pure water) = 85 : 15, ψ (acetonitrile, ultra-pure 
water) = 65 : 35, ψ (acetonitrile, ultra-pure water) = 55 : 45, 
ψ (methanol, phosphate buffer pH 7) = 55 : 45.  
 Phosphate buffer (0.05 mol L-1, pH 7) was prepared 
by dissolving 6.805 g of potassium dihydrogen phosphate 
in 1 L of mili-Q water. pH of the solution was adjusted to 7 
with 2 mol L-1 NaOH. Buffer solution was filtered under re-
duced pressure through 0.22 μm filter prior to HPLC analy-
sis. 
 Preparation of acetate buffer (pH 4) was performed 
by dissolving 10 mL of acetic acid in 2 L of mili-Q water (φ = 
0.5 %). pH was adjusted to 4 with 2 mol L-1 NaOH. 
 The results of HPLC analysis on different columns 
are given in Table 1. Final chromatographic conditions 
used in order to obtain kinetic profiles were: Waters 
Symmetry ShieldTM RP 18 (250 mm  4.6 mm; 5 μm) 
column, ψ (acetonitrile, ultra-pure water) = 55 : 45, as 
mobile phase, flow rate 1.6 mL min–1, injection volume 7 μL, 
column temperature 25 °C, detection wavelength 225 nm 
and runtime 15 min. 
General Synthetic Procedure for the 
Conversion of 7-Ethyltryptophol, 
Sampling and HPLC Analysis 
All solvents (HPLC grade) were puchased from Sigma-
Aldrich Corp. and all reagents were supplied by PLIVA TAPI 
Croatia. The experiments with 7-ethyltryptophol of 79 % 
purity were performed as follows: 5 g of the starting com-
pound (20.9 mmol of pure) was dissolved in 12 mL of meth-
anol. The solution was cooled to 15 °C and 2.89 mL of 
methyl 3-oxopentanoate (23 mmol) was added next. Ali-
quots of inorganic acid (95 to 97 % sulfuric and 37 % hydro-
chloric acid; molar equivalents with respect to -ketoester 
for each reaction are listed in Table 2) were added gradually 
within 75 min at 0 to 5 °C (ice bath) while stirring. Then re-
action mixtures were heated at 30 °C until the end of sam-
pling. After cooling at 4 to 8 °C for 1 h the product was 
filtered off, recrystallized from methanol and vacuum dried 
(average yields of isolated product are listed in Table 2).  
 In the analogous experimental procedure with 5 g of 
7-ethyltryptophol of 98 % purity (25.9 mmol) methanol (12 
mL) was also used as solvent and the volume of methyl 3-
oxopentanoate was 3.61 mL (28.6 mmol). Molar equiva-
lents of sulfuric acid with respect to -ketoester for each 
reaction and average yields are listed in Table 2.  
 The structure of etodolac methyl ester (Scheme 1) 
was confirmed by 1H, 13C and 1H-13C HMBC NMR spectros-
copy using Bruker Avance III HD 400 MHz spectrometer, 
CDCl3 as solvent and tetramethylsilane (TMS) as internal 
standard. NMR data for isolated etodolac methyl esters 
were all analogous and were as follows: 1H NMR (δ / ppm) 
9.05 (br s, 1 H, H19), 7.36 (dd, 1 H, J = 1.2 Hz, J = 7.5 Hz, H1), 
7.08-6.99 (m, 2 H, H2, H3), 4.08-3.89 (m, 2 H, H5), 3.71 (s, 3 
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H, H11), 3.05 - 2.70 (m, 6 H, H10, H6, H4), 2.23-1.94 (m, 2 
H, H8), 1.37 (t, 3 H, J = 7.6 Hz, H7), 0.85 (t, 3 H, J = 7.4 Hz, 
H9). 13C NMR (δ / ppm) 173.24 (C12), 135.88, 134.43 (C16, 
C18), 126.58, 126.13 (C15, C17), 120.36, 119.56, 115.92 
(C1, C2, C3), 108.39 (C14), 74.58 (C13), 60.61 (C5), 51.95 
(C11), 42.78 (C10), 30.64 (C8), 24.18 (C6), 22.38 (C4), 13.74 
(C7), 7.56 (C9). 
 The sampling procedure for all described experi-
ments was the same and was performed in regular time pe-
riods as indicated in Figures 4, S1–S5. A 10-μL aliquot of the 
reaction mixture was taken in different time periods and 
dissolved in 990 μL of HPLC mobile phase ψ (acetonitrile, 
ultra-pure water) = 55 : 45. A 10-μL aliquot of the resulting 
solution was additionally diluted by dissolving in 490 μL of 
HPLC mobile phase. The resulting samples were then ana-
lyzed twice by the developed HPLC method. The first ali-
quot (t = 0 min) was taken before the addition of inorganic 
acid. 
 
RESULTS AND DISCUSSION 
HPLC Monitoring of Conversion of  
7-Ethyltryptophol to Etodolac  
Methyl Ester Over Time 
In this work we selected 79 % and 98 % pure starting com-
pound and explored the influence of impurities on the time 
needed for the conversion of the indole derivative to 
etodolac precursor (R = CH3, Scheme 1). Based on the pro-
posed[17] three-step mechanism of intramolecular oxa-
Pictet-Spengler reaction we chose to vary the molar equiv-
alents of inorganic acid with respect to β-ketoester, methyl 
3-oxopentanoate. Since the product, etodolac methyl ester, 
precipitates from the reaction mixture, the decrease in  
7-ethyltryptophol concentration was monitored over time. 
 In order to get kinetic profiles of reactions catalyzed 
with different molar ratios of sulfuric and hydrochloric acid, 
HPLC method with UV detection was developed first. UV 
spectra of reactants and the product were recorded to de-
fine detection wavelength (Figure 1). Based on the results 
obtained, 225 nm wavelength was chosen for HPLC analysis 
as the optimal one. 
 The best chromatographic separation was achieved 
on Waters Symmetry ShieldTM RP 18 chromatographic col-
umn (250 mm  4.6 mm; 5 μm) using ψ (acetonitrile, ultra-
pure water) = 55 : 45 as mobile phase. As an example, the 
representative chromatogram of the mixture of 7-ethyl-
tryptophol and etodolac methyl ester acquired under the 
optimal conditions is given in Figure 2. 
 In the continuation of the work, the limit of detec-
tion (LOD) as well as the limit of quantification (LOQ) were 
determined based on signal to noise ratio of 3 : 1 and 10 : 
1, respectively. LOD for 7-ethyltryptophol amounted to 8 
ng mL–1 and 25 ng mL–1 for etodolac methyl ester, while 
LOQ was 26 ng mL–1 for 7-ethyltryptophol and 83 ng mL–1 
for etodolac methyl ester. 
 Linearity of detector response was checked in the 
concentration range from below LOQ to 150 µg mL–1. Re-
gression analysis of chromatographic data showed that de-
tector response was linear in the concentration range from 




tR / min 
Phenyl 
tR / min 
NH2 
tR / min 
Mobile phase 7-ET EME 7-ET EME 7-ET EME 
ψ (acetonitrile, acetate buffer pH = 4) = 55 : 45 2.983 9.695 2.639 6.783 1.363 1.508 
ψ (acetonitrile, ultra-pure water) = 55 : 45 2.996 9.791 2.627 6.767 1.362 1.513 
ψ (methanol, phosphate buffer pH = 7) = 55 : 45 7.589 38.394 6.889 31.314 2.271 – (a) 
ψ (acetonitrile, ultra-pure water) = 85 : 15 1.886 2.621 1.155 1.432 1.579 1.760 
ψ (acetonitrile, ultra-pure water) = 65 : 35 2.373 5.448 1.353 2.472 1.410 1.547 
(a) No separation from 7-ethyltryptophol was achieved 
 
 
Figure 1. UV spectra of 7-ethyltryptophol, methyl-3-oxo-
pentanoate and etodolac methyl ester in acetonitrile. Con-
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0.015 µg mL–1 to 150.0 µg mL–1 for 7-ET (y = 30.664 x + 
21.145, r2 = 0.9994) and from 0.0498 µg mL–1 to 150.0 µg 
mL–1 for EME (y = 22.399 x + 18.794, r2 = 0.9995). Based on 
the linear range and LOQ determined, the conditions for 
the reaction monitoring were selected.  
 In experiments carried out with p-toluenesulfonic 
acid as catalyst, the presence of dehydrating agents, such 
as activated molecular sieves or anhydrous Na2SO4, which 
aided water elimination in the second step of the reaction 
mechanism, were important in achieving high yields.[17] Re-
actions carried out with sulfuric acid, which is known dehy-
drating agent as well, resulted in shorter reactions times 
and higher yields compared to those experiments per-
formed with hydrochloric acid. High water content in con-
centrated HCl also affects reaction times needed for the 
conversion. Thus, 5 molar equivalents of hydrochloric acid 
were needed for those experiments to be even comparable 
to the reactions carried out with 1 molar equivalent of 
sulfuric acid in terms of reaction times and yields (Table 2, 
Figures S1 and S4).  
 In the case of the indole derivative of lower purity 
time needed for reaction completion was found to be 
strongly dependent of the molar equivalents of the sulfuric 
acid added (160–180 min and 120–130 min for 2 and 3 
molar equivalents, respectively). On the other hand, the re-
action times needed for the completion of the synthesis 
with the 7-ethyltryptophol of 98 % purity and the same 
molar equivalents of acid were much shorter and approxi-
mately in the same time range (90–110 min, Table 2, 
Figures 3, S2, S3 and S5). 
 
Table 2. Summary results for the conversion of 7-ET to EME over time with respect to the purity of the starting compound and 
equivalents of inorganic acid added. 
 79 % 7-ET 98 % 7-ET 
 H2SO4 HCl H2SO4 
equivalent(s) 1 2 3 5 2 3 
reaction time / min 575–585 160–180 120–130 595–605 90–110 90–110 
average yields of isolated products / % 81 86 90 77 97 98 
 
 
Figure 2. Chromatogram of the standard mixture of 7-ethyltryptophol and etodolac methyl ester. γ (7-ethyltryptophol) = 
γ (etodolac methyl ester) = 150 μg mL1. 
 
Figure 3. Conversion of 98 % 7-ethyltryptophol with 2 equi-
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Small scale experimental model for the synthesis of 
etodolac precursor is thoroughly investigated in order to 
obtain critical parameters needed for its controlled larger 
scale preparation. In the development of the HPLC method 
for the simultaneous monitoring of unreacted 7-ethyl-
tryptophol and the product over time, several columns 
with different stationary phases were used, and elution 
was performed with three different solvent mixtures in  
an isocratic mode. Finally, RP 18 column was selected  
with acetonitrile and water mobile phase. Conversion of  
7-ethyltryptophol to etodolac methyl ester was explored 
in view of the purity of the starting compound and the 
amount of acid used. 
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